A Study in Healthy Male Subjects to Understand How Savolitinib When Taken With Midazolam Behaves Inside the Body
Status:
Completed
Trial end date:
2020-03-06
Target enrollment:
Participant gender:
Summary
This study will be an open label, 2 period, fixed sequence study in healthy male subjects,
performed at a single study center in the Unites States of America. The purpose of this study
is to evaluate the effect of savolitinib on the PK of midazolam, a known cytochrome P450
(CYP) 3A substrate.